slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 85,621-85,650
Pages 3,685
Rows per page 30
Component
85,621-85,650 of 110,539
27
The slide compares vehicle control vs NVL-655 treatment across multiple cell lines and a patient-derived xenograft (PDX) model.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
03
Includes both stock market data and business financial summary in a side-by-side table format.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
04
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
Includes a scientific diagram illustrating the biogenesis of EVs (exosomes, microvesicles, apoptotic bodies).Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Voice Of Customer1 hit
11
The slide uses two scientific diagrams to illustrate the biological mechanism and molecular content of exosomes.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
15
The slide uses a grid layout to categorize patent statuses (Patent Pending vs Provisional Patent) for four distinct product lines.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
03
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Attention1 hit
06
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Need1 hit
07
Includes a list of brand ambassadors and a metric regarding their aggregate social media following.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Need1 hit
10
The chart includes a trend line annotation showing a 33% decline from Q3 '21 to Q3 '22.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The chart displays a dual-axis view of gross margin performance over time.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The chart highlights a decline in both absolute EBITDA and margin percentage over the two-year period.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide highlights Overstock's position as a top 4 player in a large, growing market.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · David Goliath1 hit
22
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Visualization1 hit
24
The central logo acts as the hub for the strategic initiatives.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
25
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
05
Pathward Financial | Results Presentation Deck | 25 slidesPathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Interest1 hit
07
The slide uses a combination of big numbers for cumulative totals and an area chart to show the reduction in share count over time.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Desire1 hit
12
The slide highlights the competitive advantage of low-cost deposits generated by the BaaS business.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
13
The chart shows a sharp increase in the Effective Fed Funds Rate in 4Q22, which correlates with an increase in the Total Cost of Deposits.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
14
The slide uses two pie charts to illustrate revenue mix and noninterest income sources.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
18
Includes disclaimer regarding regulatory purpose of data and modeling techniques.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
19
Includes three combo charts (bar + line) and a summary list of key credit metrics.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
04
PaxMedica | Investor Presentation Deck | 24 slidesPaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
09
Focuses on the regulatory milestone of an NDA filing and the associated Priority Review Voucher (PRV) opportunity.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
13
The slide uses a background map of the world to emphasize the global nature of the condition, despite the specific US prevalence statistic.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a biological process diagram to explain the drug's mechanism.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
Includes a medical illustration of the intranasal drug delivery pathway to the brain.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · Solution1 hit
17
The slide outlines a randomized, double-blind, placebo-controlled, dose-ranging proof of concept study.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
18
PaxMedica | Investor Presentation Deck | 24 slidesPaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit